Skip to Content

R332 (Pantoprazole sodium delayed release 20 mg)

Pill imprint R332 has been identified as Pantoprazole sodium delayed release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; dumping syndrome; gastritis/duodenitis; gerd (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 20 mg R332
Pantoprazole sodium delayed release
Imprint:
R332
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0332
Inactive Ingredients:
ammonia
calcium stearate
crospovidone
hydroxypropyl cellulose
hypromelloses
ferrosoferric oxide
isopropyl alcohol
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
butyl alcohol
polyethylene glycol 400
propylene glycol
shellac
sodium carbonate
ferric oxide yellow
magnesium silicate
titanium dioxide
triethyl citrate
zein
alcohol

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide